These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1931470)

  • 21. Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes.
    Scheen AJ; Jaminet C; Luyckx AS; Lefebvre PJ
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):70-6. PubMed ID: 3104218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability and pharmacodynamics of a sustained-release glibenclamide product (Deroctyl) in comparison to a standard tablet formulation (Euglucon, Daonil).
    Ayanoglu G; Witte PU; Badian M
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):479-82. PubMed ID: 6414955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the pharmacokinetics and pharmacodynamics of two commercial products containing glibenclamide.
    el-Sayed YM; Suleiman MS; Hasan MM; Abdel-Hamid ME; Najib NM; Sallam ES; Shubair MS
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):551-7. PubMed ID: 2515159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 18alpha-glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats.
    Ao Y; Chen J; Yue J; Peng RX
    Eur J Pharmacol; 2008 Jun; 587(1-3):330-5. PubMed ID: 18462715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of magnesium hydroxide on iron absorption following simulated mild iron overdose in human subjects.
    Wallace KL; Curry SC; LoVecchio F; Raschke RA
    Acad Emerg Med; 1998 Oct; 5(10):961-5. PubMed ID: 9862585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.
    Raptis SA; Hatziagelaki E; Dimitriadis G; Draeger KE; Pfeiffer C; Raptis AE
    Exp Clin Endocrinol Diabetes; 1999; 107(6):350-5. PubMed ID: 10543411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib.
    Scott G; Vinluan Reynolds C; Milosavljev S; Langholff W; Shenouda M; Rordorf C
    Clin Pharmacokinet; 2004; 43(5):341-8. PubMed ID: 15080766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers.
    Kirchheiner J; Brockmöller J; Meineke I; Bauer S; Rohde W; Meisel C; Roots I
    Clin Pharmacol Ther; 2002 Apr; 71(4):286-96. PubMed ID: 11956512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a gel forming dietary fiber, guar gum, on the absorption of glibenclamide and metabolic control and serum lipids in patients with non-insulin-dependent (type 2) diabetes.
    Uusitupa M; Södervik H; Silvasti M; Karttunen P
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):153-7. PubMed ID: 2110937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of HuangKui capsules on glibenclamide pharmacokinetics in rats.
    Liu Z; Liu S; Zhou L; Gao X; Ju W; Tan H; Yang C
    J Ethnopharmacol; 2012 Jan; 139(1):1-5. PubMed ID: 21527329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of magnesium hydroxide administration on iron absorption after a supratherapeutic dose of ferrous sulfate in human volunteers: a randomized controlled trial.
    Snyder BK; Clark RF
    Ann Emerg Med; 1999 Apr; 33(4):400-5. PubMed ID: 10092717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels of glibenclamide in diabetic patients during its routine clinical administration determined by a specific radioimmunoassay.
    Matsuda A; Kuzuya T; Sugita Y; Kawashima K
    Horm Metab Res; 1983 Sep; 15(9):425-8. PubMed ID: 6416980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The paradoxical effect of cimetidine and ranitidine on glibenclamide pharmacokinetics and pharmacodynamics.
    Kubacka RT; Antal EJ; Juhl RP
    Br J Clin Pharmacol; 1987 Jun; 23(6):743-51. PubMed ID: 3111514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of acarbose and simultaneous antacid therapy on blood glucose.
    Höpfner M; Durani B; Spengler M; Fölsch UR
    Arzneimittelforschung; 1997 Oct; 47(10):1108-11. PubMed ID: 9368703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacodynamics and pharmacokinetics of 2 glibenclamide preparations in type 2 diabetes. Intraindividual double-blind comparison of Euglucon 5 (HB 419) and Euglucon N (HB 420)].
    Haupt E; Putschky F; Zoltobrocki M; Schöffling K
    Dtsch Med Wochenschr; 1984 Feb; 109(6):210-3. PubMed ID: 6421561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The bio-availability of beta-acetyldigoxine alone and combined with aluminum hydroxide and magnesium hydroxide (Alucol).
    Bonelli J; Hruby K; Magometschnigg D; Hitzenberger G; Kaik G
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):337-9. PubMed ID: 892951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
    Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J
    Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.